See more : Krones AG (KRNTY) Income Statement Analysis – Financial Results
Complete financial analysis of Essity AB (publ) (ESSITY-B.ST) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Essity AB (publ), a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Kenedix Residential Next Investment Corporation (3278.T) Income Statement Analysis – Financial Results
- Firebird Metals Limited (FRB.AX) Income Statement Analysis – Financial Results
- Tainergy Tech Co., Ltd. (4934.TW) Income Statement Analysis – Financial Results
- Mobility One Ltd. (JE00B1Z48326.SG) Income Statement Analysis – Financial Results
- Orora Limited (ORRAF) Income Statement Analysis – Financial Results
Essity AB (publ) (ESSITY-B.ST)
About Essity AB (publ)
Essity AB (publ) develops, produces, and sells hygiene and health products and services worldwide. It offers health and medical products, including incontinence products, wound care, compression therapy, orthopedics, skincare products, and digital solutions with sensor technology. It operates in Personal Care, Consumer Tissue, Professional Hygiene, and Other segments. The company also provides consumer goods, such as incontinence products, pads, diapers, wet wipes, skincare products, intimate soaps, washable absorbent underwear, menstrual cups, toilet papers, household towels, handkerchiefs, facial tissues, and napkins; and professional hygiene products that consist of toilet papers, paper hand towels, napkins, hand soaps, hand lotions, hand sanitizers, dispensers, and cleaning and wiping products. In addition, it offers digital solutions, such as Internet of Things sensor technology enabling data-driven cleaning, as well as related service and maintenance to companies and office buildings, universities, healthcare facilities, industries, restaurants, hotels, stadiums, and other public venues. The company markets its health and medical products under the TENA, Leukoplast, Cutimed, JOBST, Actimove, and Delta-Castbrands brands through pharmacies, medical devices stores, hospitals, distributors, and care institutions, as well as e-commerce; consumer goods products under the Libero, Libresse, Nosotras, Saba, TOM Organic, Lotus, Regio, Tempo, and Vinda brands through retail trade and online; and professional hygiene products under the TORK brand through distributors and online. It serves in Europe, North America, Latin America, Asia, and internationally. Essity AB (publ) was founded in 1849 and is headquartered in Stockholm, Sweden.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 147.15B | 156.17B | 121.87B | 121.75B | 128.98B | 118.50B | 109.27B | 101.24B | 98.52B | 88.00B |
Cost of Revenue | 102.02B | 118.95B | 86.77B | 82.31B | 91.12B | 86.50B | 77.41B | 72.97B | 72.17B | 64.52B |
Gross Profit | 45.13B | 37.23B | 35.09B | 39.44B | 37.86B | 32.01B | 31.86B | 28.27B | 26.35B | 23.48B |
Gross Profit Ratio | 30.67% | 23.84% | 28.80% | 32.39% | 29.35% | 27.01% | 29.16% | 27.92% | 26.75% | 26.68% |
Research & Development | 1.74B | 1.63B | 1.51B | 1.62B | 1.53B | 1.36B | 1.24B | 1.21B | 1.06B | 1.02B |
General & Administrative | 25.66B | 26.11B | 21.62B | 22.09B | 22.32B | 20.57B | 19.13B | 16.97B | 15.25B | 14.53B |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 25.66B | 26.11B | 21.62B | 22.09B | 22.32B | 20.57B | 19.13B | 16.97B | 15.25B | 14.53B |
Other Expenses | 0.00 | 1.12B | 852.00M | 809.00M | 778.00M | 732.00M | 560.00M | 159.00M | 133.00M | 126.00M |
Operating Expenses | 27.38B | 27.22B | 22.47B | 22.90B | 23.10B | 21.30B | 19.69B | 17.12B | 15.38B | 14.65B |
Cost & Expenses | 129.40B | 146.17B | 109.24B | 105.21B | 114.22B | 107.80B | 97.10B | 90.09B | 87.54B | 79.18B |
Interest Income | 411.00M | 171.00M | 86.00M | 107.00M | 105.00M | 85.00M | 156.00M | 186.00M | 180.00M | 332.00M |
Interest Expense | 2.62B | 1.48B | 761.00M | 1.05B | 1.37B | 1.19B | 1.20B | 935.00M | 1.06B | 1.06B |
Depreciation & Amortization | 7.13B | 6.84B | 7.18B | 8.10B | 8.21B | 6.87B | 6.28B | 5.30B | 5.61B | 4.39B |
EBITDA | 20.90B | 15.44B | 20.46B | 24.89B | 22.60B | 17.64B | 18.14B | 14.38B | 15.52B | 13.07B |
EBITDA Ratio | 14.21% | 13.28% | 16.53% | 20.02% | 17.38% | 14.78% | 16.87% | 16.87% | 17.26% | 15.53% |
Operating Income | 17.75B | 9.48B | 13.20B | 16.76B | 14.35B | 10.76B | 11.91B | 9.01B | 9.68B | 8.36B |
Operating Income Ratio | 12.06% | 6.07% | 10.83% | 13.76% | 11.13% | 9.08% | 10.90% | 8.90% | 9.83% | 9.50% |
Total Other Income/Expenses | -4.96B | -1.32B | -2.79B | -958.00M | -1.31B | -1.16B | -1.18B | -858.00M | -1.42B | -740.00M |
Income Before Tax | 12.79B | 8.11B | 12.54B | 15.80B | 13.04B | 9.60B | 10.72B | 8.17B | 8.86B | 7.62B |
Income Before Tax Ratio | 8.69% | 5.19% | 10.29% | 12.98% | 10.11% | 8.10% | 9.81% | 8.07% | 8.99% | 8.66% |
Income Tax Expense | 3.28B | 2.05B | 2.73B | 4.05B | 2.83B | 1.05B | 1.94B | 3.93B | 2.28B | 1.94B |
Net Income | 9.55B | 5.57B | 8.62B | 10.23B | 9.22B | 7.89B | 8.12B | 3.80B | 6.13B | 5.21B |
Net Income Ratio | 6.49% | 3.56% | 7.07% | 8.40% | 7.15% | 6.65% | 7.43% | 3.75% | 6.22% | 5.92% |
EPS | 13.60 | 7.93 | 12.27 | 14.56 | 13.12 | 11.23 | 11.56 | 5.40 | 8.70 | 7.40 |
EPS Diluted | 13.60 | 7.93 | 12.27 | 14.56 | 13.12 | 11.23 | 11.56 | 5.40 | 8.70 | 7.40 |
Weighted Avg Shares Out | 702.34M | 702.34M | 702.34M | 702.34M | 702.34M | 702.30M | 702.30M | 702.30M | 702.30M | 702.30M |
Weighted Avg Shares Out (Dil) | 702.34M | 702.34M | 702.34M | 702.34M | 702.34M | 702.30M | 702.30M | 702.30M | 702.30M | 702.30M |
Source: https://incomestatements.info
Category: Stock Reports